Half-year report · HY
4539.TEDINET S100X2VF
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥15.9bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥32.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥15.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥122m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥76m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥48m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥443m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥62m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥205m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥62m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥163m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥294m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥44m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥163m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | −¥44m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥52.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥49.9bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥52.0bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥33.1bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥30.7bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥18.9bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥19.2bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥18.6bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.0bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥9.0bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.2bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥265m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥702m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥151m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥88m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥305m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥974m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥45.27 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.72 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-12.26 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 36.4% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.7% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 27
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥588m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥577m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥11m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | −¥3m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥11m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥11m |
| Medicinereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥15.4bn |
| Medicinereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥15.4bn |
| Medicinereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥125m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥15.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥15.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥11m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥122m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥627m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥570m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥56m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥38m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥61m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥61m |
| Medicinereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥15.1bn |
| Medicinereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥15.1bn |
| Medicinereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥4m |
| Medicinereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥38m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥15.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥61m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥76m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 540
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人 ト ー マ ツ | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)大 竹 貴 也 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)大 西 安 弘 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1InterimDuration | 15626000000 | JPY |
| Net sales (5-year summary) | InterimDuration | 15932000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 32570000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1InterimDuration | -62000000 | JPY |
| Ordinary income loss (5-year summary) | InterimDuration | 48000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 443000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1InterimDuration | -44000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | InterimDuration | 163000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 294000000 | JPY |
| Comprehensive income (5-year summary) | Prior1InterimDuration | 274000000 | JPY |
| Comprehensive income (5-year summary) | InterimDuration | -50000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 889000000 | JPY |
| Net assets (5-year summary) | Prior1InterimInstant | 18552000000 | JPY |
| Net assets (5-year summary) | InterimInstant | 18933000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 19167000000 | JPY |
| Total assets (5-year summary) | Prior1InterimInstant | 52024000000 | JPY |
| Total assets (5-year summary) | InterimInstant | 51986000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 49851000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1InterimDuration | -12.26 | |
| Basic earnings loss per share (5-year summary) | InterimDuration | 45.27 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 81.72 | |
| Diluted earnings per share (5-year summary) | Prior1InterimDuration | － | |
| Diluted earnings per share (5-year summary) | InterimDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1InterimInstant | 0.357 | |
| Equity to asset ratio (5-year summary) | InterimInstant | 0.364 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.384 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1InterimDuration | 702000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | InterimDuration | 2165000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | -265000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1InterimDuration | -88000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | InterimDuration | -151000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -1655000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1InterimDuration | 974000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | InterimDuration | 1000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -305000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1InterimInstant | 10805000000 | JPY |
| Cash and cash equivalents (5-year summary) | InterimInstant | 8991000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 7021000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 4261420 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 4261420 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 4261420 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 4261420 | |
| Number of shares held | InterimInstant_No1MajorShareholdersMember | 714000 | |
| Shareholding ratio | InterimInstant_No1MajorShareholdersMember | 0.1956 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |